« Previous
Next »
Journal of Clinical Lipidology
Volume 4, Issue 2
, Pages 99-104
, March 2010
Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia
References
- . Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriber CR, Beaudet AL, Aly WS, Vallo O editor. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001;p. 2835–2855
- . Type III hyperlipoproteinemia: analysis of two contemporary deficiencies. Ann Intern Med. 1975;82:150–157
- . Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations. Clin Chem. 2005;51:904–907
- . Diagnosis of type III hyperlipoproteinemia from total cholesterol, triglyceride, and apolipoprotein B. J Clin Lipidol. 2007;1:256–263
- Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinemia. Eur J Clin Chem Clin Biochem. 1993;31:743–747
- Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype. Clin Chim Acta. 2004;348:35–40
- . Hyperlipidaemia in patients with hypopituitarism. Acta Endocrinol. 1985;110:456–460
- . Accumulation of intermediate density lipoprotein in the plasma of cholesterol-fed hypothyroid rats. Metabolism. 1983;32:146–150
- A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis. Atherosclerosis. 1988;140:187–190
- . Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin Chim Acta. 2000;301:103–117
- . Plasma apolipoprotein E levels in hypertriglyceridemia. Horm Metab Res. 1982;14:303–306
- Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest. 1991;88:1856–1864
- . A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene deficiency and apoE4 in a severely hypertriglyceridemic patient. Atherosclerosis. 1997;130:153–160
- . Evaluation of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem. 2001;47:1579–1596
- . Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phe and —514C→T in the hepatic lipase gene. Pancreas. 2009;38:233–235
- A novel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient. Atherosclerosis. 2009;207:24–25
PII: S1933-2874(10)00043-7
doi: 10.1016/j.jacl.2010.01.004
© 2010 National Lipid Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Clinical Lipidology
Volume 4, Issue 2
, Pages 99-104
, March 2010
